Sign up
Pharma Capital

Daily CryptoCann™ Report: Top economist thinks regulation will be the end of Bitcoin; WeedMD inks supply deal in British Columbia

The Daily CryptoCann Report™ is where we report on news trending in the cannabis and cryptocurrency spaces.

 

View full WMD profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.